Suto, T., Ishiguro, M., Hamada, C., Kunieda, K., Masuko, H., Kondo, K., . . . Tomita, N. (2017). Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer. Int J Clin Oncol.
استشهاد بنمط شيكاغوSuto, Takeshi, et al. "Erratum To: Preplanned Safety Analysis of the JFMC37-0801 Trial: A Randomized Phase III Study of Six Months Versus Twelve Months of Capecitabine As Adjuvant Chemotherapy for Stage III Colon Cancer." Int J Clin Oncol 2017.
MLA استشهادSuto, Takeshi, et al. "Erratum To: Preplanned Safety Analysis of the JFMC37-0801 Trial: A Randomized Phase III Study of Six Months Versus Twelve Months of Capecitabine As Adjuvant Chemotherapy for Stage III Colon Cancer." Int J Clin Oncol 2017.